Professional Summary
Professional Overview
Patrick Schnegelsberg is a seasoned executive with extensive experience in the medical device and healthcare technology industries. He currently serves as the Chief Executive Officer and Board Member at SynCardia Systems, LLC, a leading provider of temporary total artificial heart solutions. Additionally, he holds the role of Managing Partner at The Venture Office, a strategic advisory firm, and serves as the Chairman of the Board of Directors at Acorai. Schnegelsberg is known for his expertise in driving organizational growth, fostering innovation, and leading teams to achieve ambitious goals.
Experience Summary
Current Roles
As the CEO and Board Member at SynCardia Systems, LLC, Schnegelsberg is responsible for spearheading the company's strategic direction, overseeing day-to-day operations, and driving the development and commercialization of innovative medical devices. He has a proven track record of successfully leading high-growth companies in the healthcare technology sector.
At The Venture Office, Schnegelsberg serves as the Managing Partner, providing strategic advisory services to early-stage and growth-stage ventures. In this role, he leverages his extensive industry knowledge and entrepreneurial expertise to help clients navigate the complex landscape of the healthcare industry and achieve their business objectives.
As the Chairman of the Board of Directors at Acorai, Schnegelsberg provides strategic guidance and oversight to the company, which is developing groundbreaking solutions for the treatment of heart failure.
Career Progression
Prior to his current roles, Schnegelsberg held several senior leadership positions within the medical device and healthcare technology industries. He served as the Chief Executive Officer at Syntach AB, a leading provider of cardiac assist devices, and as the Board Member at Scandinavian Real Heart. Schnegelsberg also held the role of Chief Executive Officer at procora Ltd. (An Occlutech Company) and CEO at Occlutech Ltd., where he successfully led the company's growth and expansion.
Earlier in his career, Schnegelsberg held positions at Occlutech Holding, NOLabs AB, Corporate Finance Partners (now ACXIT Capital Partners), GammaCan International Ltd., Achelous Partners, LLC, Rodman & Renshaw, and Booz & Company, among others. Throughout his career, he has demonstrated a strong ability to drive strategic initiatives, foster innovation, and deliver exceptional results.
Academic Background
Schnegelsberg holds a relevant educational background, although specific details are not provided in the information given.
Areas of Expertise
Schnegelsberg's areas of expertise include medical device and healthcare technology leadership, strategic planning, business development, merger and acquisition integration, and operational excellence. He is known for his ability to identify and capitalize on market opportunities, build high-performing teams, and deliver sustainable growth.
Professional Impact
Under Schnegelsberg's leadership, the companies he has served have experienced significant growth, achieved important milestones, and made meaningful contributions to the healthcare industry. His strategic vision, coupled with his relentless drive and commitment to innovation, have earned him a reputation as a respected leader in the medical device and healthcare technology sectors.
Conclusion
With his extensive experience, proven track record of success, and a deep understanding of the healthcare industry, Patrick Schnegelsberg is well-positioned to continue driving positive change and delivering value to the organizations he serves. His versatile expertise, coupled with his entrepreneurial mindset, make him a valuable asset in the dynamic and rapidly evolving healthcare landscape.
